Aim: The aim of this study was to describe the experiences of nurses with regard to medication errors.
Background: Medication errors result in a significant proportion of the deaths related to avoidable medical errors in hospitals.
Design: A descriptive cross-sectional study.
Method: This study was conducted on 243 nurses working in two state hospitals in Turkey. Data collection was by means of a questionnaire developed by the researchers. Medication errors were explored in three areas: types of error, contributing factors and reporting of errors.
Result: Among the most frequent types of errors were administration of drugs not ordered by the doctor, administration of a drug prepared by someone else and administration of a drug to the wrong patient. Contributing factors for medication errors included 'having to write an order in place of the physician', and 'an oral request being given in a non-urgent situation'.
Conclusion: These results show the need for a multi-disciplinary approach in the prevention of errors.
Implications For Nursing Management: Hospital administrations should maintain adequate staffing levels. Improving medication error reporting is also imperative in order to enable nurses to document all errors and potential errors as adverse events.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jonm.12216 | DOI Listing |
Pharmacol Rep
December 2024
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CEPT), Medical University of Warsaw, Banacha 1B, Warszawa, 02-097, Poland.
Sudden cessation of the drug can cause withdrawal syndrome, discontinuation syndrome, or rebound effect. The common feature of these phenomena is a quick onset, usually limited duration depending on the drug's half-life and remission after restarting the therapy. They are characterized by varying clusters of somatic, autonomic, and psychiatric symptoms.
View Article and Find Full Text PDFBMJ Open Qual
December 2024
Department of Emergency Medicine, Changi General Hospital, Singapore.
Medication errors continue to pose a significant risk to patient safety, accounting for half of the avoidable harm in healthcare systems around the world. In emergency departments (EDs), factors such as high patient loads and emergent nature of care increase the likelihood of such errors. An audit conducted at the ED of Changi General Hospital Singapore from January 2019 to July 2022 revealed that the duplicate therapy error comprised 31% of all reported medication errors.
View Article and Find Full Text PDFInt J Pharm Pract
December 2024
Department of Life Sciences, University of Bath, Bath, United Kingdom.
Objectives: To develop a tool to 'risk score' the potential harm of a medication error by estimating the probability of a range of potential consequences, and assess its feasibility, validity, and reliability.
Methods: The risk score tool described five levels of potential harm developed from an existing risk matrix. Judges estimated the likelihood of harm matching each level, from which a risk score (0-10) was calculated.
Medicine (Baltimore)
December 2024
Newborn Screening Center, Jinan Maternal and Child Care Hospital, Jinan, P.R.China.
Rationale: The high clinical heterogeneity of hypermethioninemia caused by MAT1A gene defects has resulted in a paucity of studies examining the association between clinical phenotypes, biochemical characteristics, and gene mutations in this patient group. Furthermore, the indications for therapeutic interventions in patients remain unclear. The objective of this study is to provide a foundation for clinical diagnosis, genetic counseling, and follow-up management of hypermethioninemia caused by MAT1A gene defects.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Service of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Objectives: We aimed to assess the characteristics of adverse drug reactions (ADRs) collected in a university hospital.
Methods: A retrospective analysis of ADRs spontaneously reported in the Hospital Pharmacovigilance Program database (RutiRAM) over a 13-year period was conducted. The analysis included a description of ADRs [System Organ Class (SOC)] and their seriousness, the drugs involved [level 1 of the Anatomical Therapeutic Chemical (ATC) Classification System], drug-drug interactions, medication errors, drugs 'under additional monitoring', positive rechallenge, and the 'pharmacovigilance interest' of ADRs.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!